levodopa has been researched along with carnitine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Arenas, J; Benito-León, J; Campos, Y; Gasalla, T; Jiménez-Jiménez, FJ; Martín, MA; Molina, JA; Ortí-Pareja, M; Rubio, JC | 1 |
Akamatsu, W; Fujimaki, M; Hatano, T; Hattori, N; Ishikawa, KI; Nojiri, S; Oyama, G; Saiki, S; Takeshige-Amano, H; Ueno, SI; Yamaguchi, A | 1 |
1 trial(s) available for levodopa and carnitine
Article | Year |
---|---|
Cerebrospinal fluid carnitine levels in patients with Parkinson's disease.
Topics: Acylation; Aged; Antiparkinson Agents; Carnitine; Female; Humans; Levodopa; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Reference Standards; Selegiline | 1997 |
2 other study(ies) available for levodopa and carnitine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson's Disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carnitine; Fatty Acids; Female; Humans; Levodopa; Male; Mental Status and Dementia Tests; Metabolome; Middle Aged; Mitochondria; Oxidation-Reduction; Parkinson Disease; Pilot Projects; Severity of Illness Index; Zonisamide | 2018 |